CPT 17000: Destruction of First or Only Premalignant Lesion
Medicare pays $69 and commercial payers pay $136 on average nationally for this procedure.
CPT code 17000 reports destruction of the first or only premalignant skin lesion (for example, actinic keratosis) using methods such as chemosurgery, cryosurgery, electrosurgery, or similar techniques; this is a dermatologic procedural service typically performed in an outpatient clinic or office setting to remove a single lesion for diagnostic or therapeutic purposes.
For related coverage guidance, see recent payer policy updates: Onychomycosis diagnostic testing and coverage, Topical Acne-Non-Retinoid Products, Dermatology - Vtama Drug Quantity Management Policy - Per Days.
Customize your policy alerts
Sign up for cpt 17000 policy alerts
Get alerted when payer policies referencing 17000 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National averages show a clear split between Medicare and commercial BUCA pricing for CPT 17000: Medicare’s mean is $68.90 while BUCA’s mean is $135.60, indicating BUCA reimburses about $66.70 more on average than Medicare for this service. That gap highlights how commercial contracts can sit notably above the Medicare baseline even when Medicare’s central tendency (median $68) is tight around its mean.
Dispersion analysis using the interquartile range (P75 minus P25) highlights variability across payers. Blue Cross Blue Shield has the widest IQR at $83.40 ($205.80−$137.40), followed by UnitedHealth Group at $62.50 ($128.70−$66.20) and Cigna at $66.10 ($132.60−$64.90). Aetna has a narrower spread of $39.80 ($77.80−$39.80), making it one of the tighter distributions in this set.